Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Hes1 protein is important for hair growth and regeneration, and could be a potential treatment for hair loss.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

Minoxidil treatment increased hair density in a young Asian girl with short anagen syndrome, but didn't improve hair length or thickness.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Researchers found 24 genes that change significantly and affect cashmere growth in goats; this could help increase cashmere production.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

A patient's hair loss after a browlift surgery improved on its own over 8 months.

Baicalin helps hair grow by boosting certain cell activities and speeding up hair cycle in mice.

Mackerel-derived fermented fish oil helps hair grow by activating growth pathways and increasing cell proliferation.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Blocking JAK-STAT signaling can lead to hair growth.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Keratin extract from human hair was found to promote hair growth in mice.

Hair growth is influenced by various body and external factors, and neighboring hairs communicate to synchronize regeneration.

Concentrated nanofat helps mice grow hair by activating skin cells and may be used to treat hair loss.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

A herbal mix with chickpea, holy basil, and nut grass extracts grew rat hair well, similar to a common hair growth drug.

Topical estrogen helps hair growth in menopausal women with no major side effects.

Chitosan and surface-deacetylated chitin nanofibers may help treat hair loss.

Blocking prolactin increases the activity of secondary hair follicles in cashmere goats.

All three shampoos reduced dandruff and hair loss, but ketoconazole and piroctone olamine also made hair thicker.

The new wound dressing with minoxidil and dexamethasone could speed up healing and reduce scarring in rats.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.